| abstract |
The present invention relates to the use of nicotine receptor agonists or analogs or derivatives thereof for treating inflammatory lung disease. The present invention also relates to pharmaceutical compositions comprising nicotine receptor agonists or analogs or derivatives thereof. Also provided are novel compounds of the formula:n n n n n n n n Wherein R 1 , R 2 , Xa and Ya are as defined herein.n n n n Nicotinic receptor agonists |